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Background: Luminescent semiconductor nanocrystals, also known as quantum dots (QD), possess highly desirable
optical properties that account for development of a variety of exciting biomedical techniques. These properties
include long-term stability, brightness, narrow emission spectra, size tunable properties and resistance to photobleaching.
QD have many promising applications in biology and the list is constantly growing. These applications include DNA or
protein tagging for in vitro assays, deep-tissue imaging, fluorescence resonance energy transfer (FRET), and studying
dynamics of cell surface receptors, among others. Here we explored the potential of QD-mediated labeling for the
purpose of tracking an intracellular protein inside live cells.
Results: We manufactured dihydrolipoic acid (DHLA)-capped CdSe-ZnS core-shell QD, not available commercially, and
coupled them to the cell cycle regulatory protein Cyclin E. We then utilized the QD fluorescence capabilities for
visualization of Cyclin E trafficking within cells of Xenopus laevis embryos in real time.
Conclusions: These studies provide “proof-of-concept” for this approach by tracking QD-tagged Cyclin E within cells of
developing embryos, before and during an important developmental period, the midblastula transition. Importantly,
we show that the attachment of QD to Cyclin E did not disrupt its proper intracellular distribution prior to and during
the midblastula transition. The fate of the QD after cyclin E degradation following the midblastula transition remains
unknown.
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Luminescent quantum dots (QD) are semiconductor
nanocrystals with unique spectroscopic properties. QD
have generated much interest in the past two decades,
with current and projected applications including use
as FRET donors, fluorescent labels for cellular labeling,
intracellular sensors, deep-tissue and tumor imaging
agents, sensitizers for photodynamic therapy, and vectors
for studying nanoparticle-mediated drug delivery [1]. The
advantages of QD over organic dyes and genetically engi-
neered fluorescent proteins for tagging biomolecules are
their broad excitation and narrow emission spectra,
brightness, resistance to photobleaching, and the fact that
they can be synthesized from a single material to emit a
variety of wavelengths [2]. QD have size tunable fluores-
cent properties, meaning that changes in QD size result in* Correspondence: rhartley@salud.unm.edu
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unless otherwise stated.different colors of emitted light. Larger QD emit redder
(lower energy) light while smaller QD emit bluer (higher
energy) light. Multiple molecules can be labeled with QD
of various colors and simultaneously imaged after excita-
tion with a single UV source, which prevents overheating
of cells, a quality desirable for both in vitro and in vivo
applications.
The colloidal nanocrystals most often used in funda-
mental or applied studies are spherical, with cores varying
between 15 and 120 Å in diameter. CdSe nanocrystals
are prepared by reacting organometallic precursors at
high temperatures in a coordinating solvent mixture.
This results in capping of the inorganic core with an or-
ganic layer of trioctylphosphine/trioctylphosphineoxide
mixture (TOP/TOPO) [3]. Overcoating of the CdSe
core with several layers (3–5) of wider band gap semi-
conducting material, such as ZnS or CdS permits passiv-
ation of the core surface and produces highly luminescent
CdSe-ZnS or CdSe-CdS core-shell QD [4]. In addition,
the shell protects the QD from oxidation and preventsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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onment, which is very important for in vivo applica-
tions [5]. For biological studies, QD also need to be
soluble in water. Several methods have been used to
render QD water soluble, such as exchange of native
TOP/TOPO organic surface ligand for a water soluble
surface ligand (cap exchange) [6], encapsulation within
amphiphillic molecule-copolymer micelles [7], and
coating with silica [8-11].
Despite the obvious optical advantages of QD-assisted
visualization, most fluorescent QD labeling is being uti-
lized either outside of cell boundaries or directly on the
surface of the plasma membrane. Targeted labeling of
biological molecules with QD is utilized for a variety
in vitro applications, including using antibody-coupled
QD for immunoassays, immunochromatography assays
[12-16], and as biosensors that are based on QD as
FRET donors [17,18]. The antibody mediated specificity
approach of tagging proteins on the cell surface i.e., re-
ceptors or receptor ligands, allows for either studying
their dynamics via single-particle tracking [19-21] or tar-
geting tumor cells for detection and destruction [22-24].
QD have also been used for cell-tracking in Xenopus
laevis embryos, either unconjugated [7], or conjugated
to a nuclear localization signal [25] in order to track
morphogenetic movement of cells during development.
As protein function is directly linked to its localization
within the cell, accurate assessment of protein spatio-
temporal dynamics is crucial. Moreover, protein localization
to different compartments within a cell provides an import-
ant regulatory role. We set out to use QD to track the
movement of Cyclin E, a cell cycle regulatory protein
whose expression is restricted to G1/S phase of the mam-
malian cell cycle, where it mediates this cell cycle transi-
tion. Cyclin E has been shown to shuttle between the
nucleus and cytoplasm in mammalian cells [26]. This
shuttling makes sense as two of the best defined functions
of Cyclin E, initiation of DNA replication and centrosome
duplication, require its presence in the nucleus and cyto-
plasm, respectively. Cyclin E shuttling and its degradationFigure 1 Transmission electron microphotographs of the synthesized CdSe
is 10 nm.after the G1/S transition is regulated by phosphorylation
and other post-translational modification. Malfunction of
mechanisms controlling Cyclin E leads to its elevation in
many types of human malignancy, where it is often
present throughout the cell cycle [27]. Experimental evi-
dence indicates that Cyclin E elevation is a cause rather
than an effect of tumorigenesis [28,29].
In this study, we synthesized DHLA-capped CdSe-ZnS
QD, as they are not available commercially, and use them
to label polyhistidine (His6)-tagged recombinant Cyclin E.
We demonstrate feasibility of QD-assisted tracking inside
cells by visualizing the intracellular localization of QD-
labeled Cyclin E in live embryos in real time during
early cell division cycles.
Results
CdSe-ZnS core-shell quantum dots with the photolumi-
nescence emission peak of 564 nm were manufactured
according to the procedure of Clapp et al. [4]. To make
the QD soluble in water, we utilized the cap exchange
strategy, exchanging TOP/TOPO with dihydrolipoic acid
(DHLA). DHLA is a bifunctional ligand, containing a
bidentate thiol moiety on one end, allowing its stable at-
tachment to the inorganic QD surface, and an opposing
hydrophilic end group, which permits its aqueous dis-
persion [4]. The DHLA-capped QD maintain their high
photoluminescence and quantum yield. After synthesis
and cap exchange, the morphology of DHLA coated
CdSe-ZnS (QD564) was assessed by transmission elec-
tron microscopy (TEM). As seen in Figure 1, the QD
were homogeneous, of high crystallinity (Figure 1c),
consistent size (4.1 ± 0.88 nm in diameter) and shape
(spherical) and did not form aggregates, as shown in
Additional file 1.
Next, we coupled the (His6)-tagged cyclin E to QD
(Figure 2) and confirmed the attachment by measuring
photoluminescence (PL) and quantum yield (QY). The
observed 30% increase in PL intensity and 0.4% in-
crease in QY (from 2.2% to 2.6%) of conjugated versus
unconjugated QD confirmed successful bonding of-ZnS QD. (a) Scale bar is 50 nm. (b) Scale bar is 20 nm. (c) Scale bar
Figure 2 Schematic showing experimental design. (a) DHLA capping of CdSe-ZnS (QD564) and subsequent conjugation of (His6)-Cyclin E
(modified from [5]). (b) Microinjection of (QD564)-His6Cyclin E into 2-cell Xenopus embryos and (c) confocal imaging of microinjected pre-MBT
and MBT Xenopus embryos. In (a) the DHLA molecule contains a bidentate thiol moiety on one end, allowing its stable attachment to the
inorganic QD surface. Coupling of (His6)-Cyclin E to QD is achieved via strong metal affinity between the histidine tag of the protein and Zn
+2
atoms on the QD surface. The schematic is not to scale.
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file 2).
(QD564)-His6Cyclin E complexes were microinjected
into 1 cell of a 2-cell Xenopus laevis embryo between
1.5-2 hours post fertilization (hpf ) and visualized in live,
developing embryos by confocal microscopy. Embryos
were viewed between 4 to 7 hpf (stages 61/2-8), during
which time embryos undergo cell divisions 5–12. This
developmental period encompasses the midblastula tran-
sition (MBT), an important transition that begins around
6 hpf (stage 8) when global transcription initiates, cell
motility begins, and the rapid embryonic cell cycle is re-
modeled to the adult cell cycle. Remodeling adds gap
(G1 and G2) phases to a cell cycle that consists of rapid
oscillations between DNA synthesis (S phase) and mi-
tosis (M phase) [30]. Cyclin E is known to be nuclear at
the MBT [31] but during the time we were performing
these experiments, its localization before the MBT had
not been determined. Therefore, we assessed Cyclin E
localization before and during the MBT.
Images of embryos taken at 4 hpf, about 2 hrs post-
injection (Figure 3a and c) show that localization of
(QD564)-His6Cyclin E was cytoplasmic prior to the MBT,
as evident from the diffuse staining seen within individual
blastomeres (large cells). At the MBT (6 hpf), (QD564)-
His6Cyclin E began to accumulate in the nuclei of the cells
(Figure 3d and f) (white arrows). The daughter cells that
originated from the uninjected cell of the 2-cell embryoFigure 3 Localization of (QD564)-His6Cyclin E in live pre-MBT (4 hpf, 64-cell em
One cell of embryos at the 2-cell stage was microinjected with (QD564)-His6Cy
channel; (b, e) light channel; (c, f) merged fluorescence and light channe
were viewed with a 10X objective on a Zeiss LSM 510 confocal microscop
Acquisition software. Scale bars are 100 μM. At least 20 embryos were injelack luminescence and serve as a negative control for QD
detection, as only cells derived from the injected cell
should contain the QD. The cells derived from the unin-
jected blastomere can be clearly seen as they lack lumines-
cence in Figure 3c and f, which show merged images of
the UV and light channels. Gap junctions and cytoplasmic
bridges couple cells of the early embryo during cleavage
[32,33]. Gap junctions are too small for QD to cross
(1–2 nm). Lack of QD luminescence in the sister cell at
2-cell or 4-cell stages (not shown), as well as in a very
specific subset of cells at later stages (Figure 3), show
that QD are not diffusing via gap junctions or cytoplasmic
bridges (QD are injected after the first cleavage division is
complete). It should also be noted that individual cells of
the embryo become progressively smaller as embryos con-
tinue to divide without growing during this developmental
timeframe (see Figure 2c for a graphical illustration).
Our tracking results of Cyclin E labeled with QD are in
agreement with a previous study that reported nuclear
localization of Cyclin E at the MBT [31]. They are also con-
sistent with our published work showing the localization
pattern of endogenous and exogenous Cyclin E [34]. Simi-
larly to these published results, Figure 4 shows immuno-
fluorescence staining of Myc6-GFP-Cyclin E in embryos,
produced from in vitro transcribed mRNA also injected at
the 2-cell stage. The embryos were probed with an antibody
to the Myc6-tag followed by an Alexa Fluor488 conjugated
secondary antibody. Exogenous Cyclin E was diffuselybryo, a-c) and MBT (6 hpf, 2048-cell embryo, d-f) Xenopus laevis embryos.
clin E and visualized using confocal microscopy. (a, d) fluorescence
ls. Nuclei are marked with white arrowheads in panels b, f. Embryos
e equipped with a META detector, and analyzed using LSM510 Image
cted and viewed in at least 3 separate experiments.
Figure 4 Localization of exogenous Cyclin E in pre-MBT and MBT Xenopus laevis embryos. One cell of 2-cell embryo was microinjected with
in vitro transcribed Myc6−GFP-Cyclin E RNA, collected at indicated time points, and the translated protein detected in fixed and stained embryos.
For immunofluorescence analysis of Cyclin E localization, embryos were collected at 4 hpf, pre-MBT (a-c) or at 6 hpf, MBT (d-f). (a, d) Embryos
were fixed and stained with an antibody against the Myc6 tag (αMyc) followed by an Alexa488 conjugated secondary antibody. (b, e) Embryos
were counterstained with DAPI to visualize the nuclei. (c, f). Merged image of the Alexa488 and DAPI. White arrowheads in d-f indicate nuclei.
Embryos were viewed with a 10X objective on a Zeiss LSM 510 confocal microscope equipped with a META detector, and analyzed using
LSM510 Image Acquisition software. Scale bars are 100 μM. At least 20 embryos were injected in at least 3 separate experiments, with at least 5
embryos fixed per timepoint for analysis.
Figure 5 Cyclin E accumulates in the nucleus of live Xenopus laevis
embryos at the MBT (6 hpf). One cell of the 2-cell embryo was
microinjected with in vitro transcribed Myc6-GFP-Cyclin E RNA and
the translated protein visualized in live embryos using confocal
microscopy in real time. (a, b) Fluorescence channel, Z stack images
#5 and #8 from the top, respectively. Nuclei are marked with white
arrowheads. (c) Light field image. A 3D image is shown. Scale bars
are 100 μM. Embryos were viewed with a 10X objective on a Zeiss
LSM 510 confocal microscope equipped with a META detector, and
analyzed using LSM510 Image Acquisition software. At least 20
embryos were injected in at least 3 separate experiments.
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accumulated in the nuclei at the MBT in fixed embryos
(Figure 4d). Figure 4b shows the diffuse distribution of
DAPI in the pre-MBT embryos, due to its inability to
diffuse though the lipid-rich cytoplasm even in fixed
embryos. Figure 4c is a merged image of the Alexa
Fluor488 and DAPI channels. Figure 4e shows DAPI
stained nuclei in an MBT embryo (white arrowheads),
while Figure 4f shows the coincidence of DAPI and ex-
ogenous cyclin E. DAPI easily stains the nuclei in MBT
embryos as the ratio of cytoplasm to nucleus is greatly
reduced in the smaller cells. Cells in mitosis (identified
by the condensed chromatin and mitotic figures) have
diffusely distributed cytoplasmic cyclin E (Figure 4d-f ),
also in agreement with previous studies [30].
Additional GFP imaging of fluorescent Myc6-GFP-
Cyclin E in live embryos confirmed its residence in the
nucleus at the MBT in merged (Figure 5a) and fluores-
cence (Figure 5b) images (white arrowheads). Altogether,
these results provide evidence that attachment of QD to
Cyclin E leads to excellent tracking capabilities, without
altering the ability of a protein to follow a proper and
timely localization pattern intracellularly.
We also assessed potential cytotoxicity of the (QD564)-
His6Cyclin E complexes by carefully monitoring em-
bryo morphology and survival for up to 3 days aftermicroinjection. In a typical experiment, 20 embryos
each were microinjected with either QD solution or
solvent (water). Of these 20 embryos, 10–15 survived
in both the QD-injected and Solvent-injected embryos.
Of these, approximately 6–10 developed into free-
swimming tadpoles. This number varied depending on
the quality of the eggs and sperm. Germ cell quality
Brandt et al. Journal of Nanobiotechnology  (2015) 13:31 Page 6 of 9varies with age of the female and male frogs, the num-
ber of times the female frog has been ovulated, as well
as environmental factors such as temperature. Injected
embryos progressed through the blastula stage, gastru-
lated normally, and became free-swimming tadpoles.
We were able to visualize QD-mediated fluorescence
in embryos microinjected with (QD564)-His6Cyclin E
complexes for up to three days after microinjection
without any obvious deleterious effects. These results
suggest that toxicity associated with the proposed ap-
plication of QD-assisted tracking in Xenopus embryos
remained low. This low toxicity differs from reports
using commercial QD in Xenopus embryos, which
showed variable cytotoxicity [25], likely due to variable
overcoating. The low toxicity of our QD is probably
due to consistent overcoating, which can be controlled
when they are synthesized in lab.Discussion
In this paper we conducted “proof-of-principle” experi-
ments for an exciting application for engineered nano-
scale products in the biomedical field, tracking of
intracellular protein inside cells. We accomplished both
objectives we set out to achieve. First, we successfully
synthesized functional DHLA-capped CdSe-ZnS QD
specifically tailored to our application of attachment of
recombinant (His6)-Cyclin E protein to its surface. Sec-
ond, we followed our QD-tagged Cyclin E complexes in-
side the cells of developing Xenopus embryos in real
time, which allowed us to discriminate between cyto-
plasmic Cyclin E localization before the MBT (4 hpf)
and its accumulation in the nucleus at the MBT (6 hpf).
Therefore we provide evidence for the feasibility of this
approach.
For our experiments we chose ZnS overcoated CdSe
quantum dots capped with DHLA. Cap exchange with
DHLA not only renders QD water soluble [35], but also
allows direct attachment of Histidine-tagged proteins.
Alternatively, a more traditional conjugation approach
involves the use of the EDC (1-ethyl-3-(3-dimethylami-
nopropyl) carbomide) crosslinking agent that reacts with
carboxyl groups on the QD surface to the primary amine
groups of the protein. The direct coupling strategy that
we utilized has several unique advantages. First, it allows
a unidirectional attachment of protein to the QD. Sec-
ond, QD-protein complexes are less prone to aggrega-
tion in neutral and acidic buffers. Third, the attachment
of His-tagged proteins to the DHLA capped quantum
dots is mediated by a strong metal affinity between the
His6-tag and Zn
2+ atoms of the QD shell [5] (Figure 2),
with a dissociation constant (Kd) of 1 × 10
−13. This inter-
action is stronger than most antibody binding, which has
a Kd of 1×10
−6-10−9 [36].Unlike most mammalian cells, Xenopus laevis embryos
provide an ideal model for a straightforward and effi-
cient intracellular delivery of QD-protein complexes.
Since QD-His6-protein complexes are stable at physio-
logical pH, they can be microinjected into the 1- or 2-
cell (or even later), 1–1.5 mm diameter Xenopus embryo
and imaged in real time in vivo. One advantage of self-
synthesized QD is that the synthesis, overcoating and
capping can be carefully controlled, resulting in low
cytotoxicity after microinjection. Another advantage is
that QD are too large to pass through the numerous gap
junctions that couple cells in the early embryo [32,33],
allowing tracking of only the progeny of the injected cell.
One disadvantage of imaging live Xenopus embryos, is
that it is very difficult to stain and image the nuclei.
DAPI and other dyes cannot efficiently diffuse through
the lipid rich cytoplasm, necessitating fixation and stain-
ing of the embryos. Visualizing the nuclei in living em-
bryos can be accomplished by producing transgenic frogs
expressing GFP-tagged nuclear membrane proteins [37]
or by coupling QD to a nuclear localization signal [25],
which in our case would have interfered with monitoring
cyclin E intracellular localization.
QD were detected in the embryos past the time that
endogenous and exogenous cyclin E are normally de-
graded [34]. Based on our prior studies, we assume that
the cyclin E1 conjugated to the QD was likely degraded
following the MBT but that the QD remain. It is possible
that cyclin E conjugated to the QD is not phosphorylated
and therefore not degraded at the developmentally appro-
priate time. As the time period of interest to us in this
study was prior to the time that cyclin E is degraded
physiologically, we did not ask if cyclin E was degraded
with normal kinetics. This is an intriguing question that
will be pursued in future studies.
Conclusions
Our approach provides an excellent alternative to the
more commonly used traditional method of genetic-
ally encoded fluorophores, with its sometimes cum-
bersome and labor intensive cloning steps and also
eliminates the risks of fusing the large protein moiety
to the native protein (~30 kDa in case of GFP, YFP,
and RFP) that can lead to protein misfolding, missort-
ing, loss of fluorescent properties, or even changes in
the host protein behavior and activity. Even though
failures are seldom reported, many representative
examples of altered fusion protein integrity are
present in the literature [38-44]. Moreover, the QD-
based approach is highly beneficial due to inherent
fluorescent signal longevity of QD that allow deeper
imaging during prolonged periods of time throughout
embryo development with the additional capabilities
of cell lineage tracing. It is widely applicable to other
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Caenorhabditis elegans, and mouse blastocysts as well
as to attached and suspended cells where cytoplasmic/
nuclear microinjections are either desirable or permis-
sible [45]. With the future advances in methods for
cargo delivery inside eukaryotic/mammalian cells
across lipid bilayers and the commercial availability of
various QD products, the application of this method
will be vastly expanded.Methods
CdSe-ZnS quantum dot preparation
QD were prepared using a stepwise approach consisting
of core CdSe nanocrystal growth, overcoating with five
layers of ZnS, size selective precipitation, and surface lig-
and exchange and purification [36]. Growth of nanocrys-
tals was monitored by a change in the absorption
spectrum by UV–VIS spectroscopy. QD were made
water soluble through exchanging the native capping
shell (trioctylphosphine (TOP)/trioctylphosphine oxide(-
TOPO)/hexadecylamine) (Sigma Aldrich, St. Louis, MO)
with freshly prepared DHLA [4] . DHLA was prepared
by ring opening of the DHLA precursor, thioctic acid
(Sigma Aldrich, St. Louis, MO) using NaBH4 (Fisher,
Waltham, MA) as a reducing agent in aqueous solution
(Figure 2) [4,46] followed by DHLA distillation to re-
move impurities. The QD morphology was assessed by
transmission electron microscopy.Optical characterization
UV–VIS absorption spectra were obtained at room
temperature using a Varian Carey 400 Spectrophotom-
eter. Each aliquot was quenched directly in a UVcell con-
taining toluene and the spectra were collected from 300
to 800 nm. QD photoluminescence (PL) and quantum
yield (QY) were measured on a Horiba Jobin-Yvon
Fluorolog-3 Spectrofluorometer with the excitation and
emission monochromators both set at 1 nm. Additional
file 2 shows results of this analysis. The optimal excita-
tion wavelength of 450 nm was determined from PL exci-
tation spectroscopy measurements. QY measurements
were performed as described [47] using the Fluorolog-3
integrating sphere attachment and a liquid sample
holder. QY determination involves five separate spectral
measurements: three excitation scatter spectra taken for
1) an empty integrating sphere, 2) integrating sphere with
the sample inside directly hit with the excitation light, 3)
integrating sphere with the sample excited indirectly by
the excitation light scattered by the integrating sphere;
and two photoluminescence spectra taken for 4) the sam-
ple inside the integrating sphere directly hit by the excita-
tion light, and 5) the sample inside the integrating sphereexcited indirectly by the excitation light scattered by the
integrating sphere.
Transmission electron microscopy
Transmission electron microscopy (TEM) was used to
verify size and quality of the cap-exchanged QD. An
aliquot of the CdSe-ZnS dots was placed onto a carbon
coated TEM grid (300 mesh) and allowed to dry for ei-
ther 0.5 hour or overnight. The QD were imaged using
either a Phillips CM 30 TEM at 300 kV accelerating
voltage (Figure 1a and c) or a Hitachi H7500 equipped
with an AMT XR60 camera (Figure 1b). Image J soft-
ware was used to determine QD size, which was 4.1 ±
0.88 nm (average of 20 non overlapping QD with vis-
ible borders).
Recombinant protein purification and conjugation to QD
The full-length open reading frame of Cyclin E was sub-
cloned into Pepex vector [31], expressed in E. coli,
grown at 37°C to an OD600 of 0.7, then induced with a
final concentration of 1 mM of isopropyl-β-D-thio-
galactopyranoside (Promega, Madison, WI) and grown
to an OD600 of 1. The Pepex vector contains a DNA se-
quence specifying a string of six histidine residues at the
amino terminus of the inserted coding region for a pro-
tein of interest. The result is expression of a recombin-
ant protein with a 6xHis tag fused to its amino-
terminus. E. coli cells were lysed followed by centrifuga-
tion and the supernatant loaded onto BioRad (Hercules,
CA) econo-pack columns filled with Ni-NTA agarose
(Qiagen, Ventura, CA) for purification (according to the
manufacturer’s specifications). His6-Cyclin E was eluted
by addition of phosphate buffered saline containing
imidazole (Sigma-Aldrich, St. Louis, MO). Protein qual-
ity and quantity were assessed by SDS-PAGE and
visualization on Coomassie stained gels. (His6)-Cyclin E
attachment to DHLA capped QD was carried out by
addition of an equal amount of (His6)-Cyclin E (in phos-
phate buffered saline) to QD in an aqueous solution of
10 mM sodium tetraborate buffer (pH 9.5); the mixture
was incubated for 15 min at room temperature. pH was
tightly controlled to 9.5 during all steps.
QD intracellular delivery and microscopy
X. laevis embryos were obtained by inducing egg lay-
ing with hormones followed by in vitro fertilization
using standard methods [48], except albino females
were used for egg laying. Fertilized embryos were
dejellied using 2% cysteine–HCl, pH 7.8, then main-
tained in 0.1X Marc’s Modified Ringer’s (0.1X MMR).
Microinjections were performed in 4% Ficoll in 0.33X
MMR [49]. Embryos were microinjected into the ani-
mal pole of one cell at the two-cell stage with 27.6 nl
of (QD564)-His6Cyclin E. Embryos were staged
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bryos were microinjected, placed in depression slides
containing 0.1X MMR in 3% Ficoll and imaged live at
the stated time post-fertilization. An empirically
chosen constant exposure time was used for imaging
on a Zeiss LSM510 confocal microscope equipped
with a META detector and analyzed using LSM510
Image Acquisition software. The Z step size was
70.71 μm. The pixel size was 2.54 μm × 2.54 μm.
Immunofluorescence analysis
The Cyclin E coding sequence (Genbank accession no.
Z13966) in the pCS2mt-GFP vector (Addgene, Cam-
bridge, MA) was used to express Myc6-GFP-tagged
cyclin E (Myc6-GFP-Cyclin E), in Xenopus embryos
for live imaging (Figure 5) or for immunofluorescence
analysis (Figure 4), as previously described [34].
pCS2mt-GFP-cyclin E plasmid was linearized with
Not I and transcribed with SP6 RNA polymerase ac-
cording to the manufacturer’s instructions (Promega,
Madison, WI). 1–2 μg of the in vitro transcribed RNA
was analyzed on a formaldehyde gel to check quality.
Capped RNA was injected into 1-cell of a 2-cell em-
bryo (0.5 ng), between 1.5–2 hours post-fertilization.
Five embryos were collected at the indicated time
points and either imaged live or fixed in 3.7% formal-
dehyde/phosphate buffered saline (PBS) for 2 hours
on a Nutator shaker. Embryos were then transferred
into Dent’s fixative (4 parts of MeOH and 1 part
DMSO), and incubated at − 20°C for at least 48 hours.
Embryos were rehydrated in a graded series of metha-
nol and washed twice for 10 min in PBS. Rehydrated
embryos were hemi-sectioned and all incubations and
washes were performed at 4°C on a Nutator. As GFP
fluorescence could not be easily detected in the fixed
embryos (not shown), hemi-sectioned embryos were
next incubated in anti-Myc (1:2,000; Cell Signaling
Technology, Danvers, MA) in PBS containing 0.05%
Tween20 (PBT) overnight in order to detect the Myc
tag. The embryos were washed four times with PBT,
and incubated in Alexa Fluor 488 conjugated goat-
anti-mouse (Molecular Probes, Eugene, OR) in PBT
(1:200) overnight. Embryos were washed 3 times with
PBT, nuclei counterstained with 4’,6’-diamidino-2-phe-
nylindole (DAPI) in PBS (1:3,000 dilution of 1 mg/ml)
for 30–60 min, washed extensively with PBS, and
mounted in depression slides using Vectashield
mounting media (Vector Laboratories, Burlingame,
CA) and coverslipped. Empirically chosen acquisition
parameters was used for imaging on a Zeiss LSM 510
confocal microscope equipped with a META detector,
and analyzed using LSM510 Image Acquisition soft-
ware. The Z step size was 70.71 μm. The pixel size
was 2.54 μm × 2.54 μm.Additional files
Additional file 1: Figure S1. DHLA coated CdSe-ZnS (QD564) solution.
(a) Photograph of 0.6 ml clear-walled PCR tubes containing solvent
(water, left) or quantum dot solution (right), showing uniform quantum
dot dispersal. (b) Stereomicroscopic image of droplets of solvent (water,
left) or quantum dot solution (right) under bright field illumination. The
dotted circles on the droplets are a reflection of the ring light on the
stereomicroscope. Scale bar is 3 mm. (c) Stereomicroscopic image of
droplets of solvent (water, left) or quantum dot solution (right) under UV
illumination. Identical field is shown, except (b) is bright field and (c) UV
illumination. Droplets were viewed using a Leica MZ FLIII fluorescence
stereomicroscope equipped with a Leica GFP1 filter set (ex 425/60, em
480 long pass). Photographs were taken with a Photometrics Coolsnap
ES camera.
Additional file 2: Figure S2. (a, b) Photoluminescence spectra of
DHLA-CdSe-ZnS (QD564) before (a) and after (b) conjugation to (His6)
Cyclin E. (c, d ) Results of quantum yield measurements of DHLA-CdSe-
ZnS (QD564) before (c) and after (d) conjugation to (His6)Cyclin E
represented by excitation scatter spectra (upper panel) and the
corresponding PL spectra (lower panel) of the samples. The excitation
scatter spectra show the actual spectral content of the excitation source
(Xenon lamp) scattered by the integrating sphere.Abbreviations
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